Who: U.S. Department of Health and Human Services Office of Inspector General, the FDA’s Office of Criminal Investigations, the Defense Criminal Investigative Service, and the Defense Health Agency.

When: May 9, 2016, October 2010 – May 2011.

Where: Lodi, California.

How: Investigation by FDA-OCI

Additional details: One drug the Kiralys purchased from Richards Pharma was Altuzan, the foreign version of the approved cancer medication Avastin. The FDA tested a batch of Altuzan that the Kiralys had purchased from Richards Pharma and determined that it lacked active ingredient bevacizumab, and was in fact counterfeit.